Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Sartorius Stedim Biotech a leading partner to the biopharmaceutical industry and Nanotein Technologies a developer of nextgeneration immune cell activation reagents have entered into a partnership As part of the collaboration
Minghui Pharmaceutical a latestage clinical biopharmaceutical company today announced the closing of a USD million PreIPO financing led by new investors OrbiMed and coled by Qiming Venture Partners
ReShape Lifesciences Nasdaq RSLS announced today that its shareholders have approved all of the proposals necessary to complete the previously announced merger with Vyome Therapeutics which is expected
Senhwa Biosciences Inca new drug development company focusing on firstinclass therapeutics for oncology rare diseases and infectious diseases today announced that US National Cancer Institute NCI sponsors
As part of our ongoing commitment to environmental stewardship and industry leadership in sustainable clinical research LabConnect is proud to announce our partnership with KitsLife an initiative of the MedSurplus Alliance
Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand has solidified its position as one of the worlds leading suppliers of pegfilgrastim following the successful acquisition of UDENYCA pegfilgrastimcbqv...
ViruSure a global leader in pathogen safety testing for biopharmaceuticals and Oxford Nanopore Technologies Oxford Nanopore LSE ONT the company behind a new generation of molecular
Celltrion Inc today announced that the US Food and Drug Administration FDA has approved an expanded indication of the intravenous IV formulation of AVTOZMA tocilizumabanoh
Clinical development manufacturing and commercialization of innovative therapeutics today announced the Taiwan Food and Drug Administration TFDA has approved the supplementary application for NEFECON
XtalPi a leading global technology company in integrating artificial intelligence AI and robotics for drug and materials discovery announced a transformative strategic collaboration with DoveTree Medicines a biotechnology pioneer founded by renowned...
